Clearside Biomedical, Inc CLSDQ
$0.25
Last Updated: Jul 13, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
CLSDQ Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Clearside Biomedical, Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Clearside Biomedical, Inc. Stock Analysis CLSDQ
United States Health Care Nano Cap Clearside Biomedical, Inc. is a biopharmaceutical company that delivers therapies to the back of the eye through the suprachoroidal space. The company is headquartered in Alpharetta, Georgia and currently employs 32 full-time employees. The company went IPO on 2016-06-02. The firm's SCS injection platform, utilizing its patented SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases. The firm is developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector. The firm's lead program, CLS-AX (axitinib injectable suspension), for the treatment of neovascular age-related macular degeneration (wet AMD). The company developed and gained approval for its product, XIPERE (triamcinolone acetonide injectable suspension) for suprachoroidal use, which is available in the United States through a commercial partner.
Clearside Biomedical, Inc (CLSDQ) Chart
Financial Metrics & Statements of Clearside Biomedical, Inc (CLSDQ)
FAQ's for Clearside Biomedical, Inc (CLSDQ)
- As of August 2026, Clearside Biomedical, Inc CLSDQ is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Clearside Biomedical, Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Clearside Biomedical, Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Clearside Biomedical, Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Clearside Biomedical, Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Clearside Biomedical, Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Clearside Biomedical, Inc (CLSDQ)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
